Barbara Hero

发表

IT Infrastructure for Merging Data from Different Clinical Trials and Across Independent Research Networks

Günter Schreier, Dieter Hayn, Markus Falgenhauer, 2016, MIE.

A method for finding consensus breakpoints in the cancer genome from copy number data

Thomas Lengauer, Konstantin Halachev, Laura Tolosi, 2013, Bioinform..

Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.

Derek Stephens, Barbara Hero, Samuel L Volchenboum, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mutational dynamics between primary and relapse neuroblastomas

Sven Rahmann, Barbara Hero, Christopher Schröder, 2015, Nature Genetics.

Histone Deacetylase 8 in Neuroblastoma Tumorigenesis

Barbara Hero, Annette Kopp-Schneider, Andreas von Deimling, 2009, Clinical Cancer Research.

Subclassification and Individual Survival Time Prediction from Gene Expression Data of Neuroblastoma Patients by Using CASPAR

Roland Eils, Lars Kaderali, Barbara Hero, 2008, Clinical Cancer Research.

Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.

Roland Eils, Barbara Hero, Frank Berthold, 2007, Cancer letters.

FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.

Barbara Hero, Frank Berthold, F. Berthold, 2003, Medical and pediatric oncology.

Neuroblastoma: biology and molecular and chromosomal pathology.

Barbara Hero, Frank Berthold, Frank Westermann, 2003, The Lancet. Oncology.

Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas

Rainer König, Axel Benner, Barbara Hero, 2008, Genome Biology.

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

Barbara Hero, Andreas Faldum, David Machin, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sample size calculation for the one-sample log-rank test.

Barbara Hero, Frank Berthold, Andreas Faldum, 2015, Statistics in medicine.

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Roland Eils, Gudrun Schleiermacher, Barbara Hero, 2014, Clinical Cancer Research.

Prognostic impact of gene expression-based classification for neuroblastoma.

Roland Eils, Lars Kaderali, Gudrun Schleiermacher, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors

Vikas Prasad, Barbara Hero, Frank Berthold, 2017, Klinische Pädiatrie.

Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome

Barbara Hero, Frank Berthold, Benedikt Brors, 2006, Clinical Cancer Research.